Abstract
The purpose of this chapter is to review the basic principles and clinical applications of advanced magnetic resonance imaging (MRI) of soft tissue tumors, including dynamic contrast-enhanced MRI (DCE-MRI), diffusion MRI, and proton nuclear magnetic resonance (NMR) spectroscopy. DCE-MRI is a method of physiological imaging, based on ultrafast imaging, with the possibility of following the early enhancement kinetics of a water-soluble contrast agent after intravenous bolus injection. This technique provides clinically useful information, by depicting tissue vascularization and perfusion, capillary permeability, and composition of the interstitial space. Diffusion MRI provides quantitative and qualitative information on tissue cellularity, cell membrane integrity, and the interstitial space. NMR spectroscopy characterizes molecules in soft tissue tumors. The most important advantages of these techniques are their abilities to monitor response to preoperative chemotherapy, to identify areas of viable tumor before biopsy, to differentiate tumor tissue from peritumoral edema, and to provide physiological information for improved tissue characterization and detection of residual or recurrent tumor tissue after therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brasch RC (1992) New directions in the development of MR imaging contrast-media. Radiology 183:1–11
Verstraete KL, Dedeene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M (1994) Benign and malignant musculoskeletal lesions – dynamic contrast-enhanced MR-imaging – parametric first-pass images depict tissue vascularization and perfusion. Radiology 192:835–843
Wolf GL (1991) Contrast agents in spine and body MRI: introduction. In: Hasso AN, Stark DD (ed) American Roentgen Ray Society – categorical course syllabus: spine and body magnetic resonance imaging. Reston, Congres of ARRS in Boston, 1991. Reston, VA, USA pp 111–115
Dean PB, Kormano M (1977) Intravenous bolus of 125I-labeled meglumine diatrizoate. Early extravascular distribution. Acta Radiol Diagn (Stockh) 18:293–304
Kormano M, Dean PB (1976) Extravascular contrast material: the major component of contrast enhancement. Radiology 121:379–382
Tong CY, Prato FS, Wisenberg G et al (1993) Measurement of the extraction efficiency and distribution volume for Gd-DT-PA in normal and diseased canine myocardium. Magn Reson Med 30:337–346
Tong CY, Prato FS, Wisenberg G et al (1993) Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentetate dimeglumine. Magn Reson Med 30:332–336
Verstraete KL et al (1992) Dynamic contrast enhanced MRI of musculoskeletal neoplasms: different types and slopes of TICs (abstract). Proceedings of Society of Magnetic Resonance in Medicine. Berkely, p 2609
Debaere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, Dipaola M (1992) Osteosarcoma after chemotherapy – evaluation with contrast material enhanced subtraction MR imaging. Radiology 185:587–592
Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD (1992) Assessment of osteosarcoma response to preoperative chemotherapy using dynamic flash gadolinium-DTPA-enhanced magnetic-resonance mapping. Invest Radiol 27:367–373
Konig H, Sieper J, Wolf KJ (1990) Rheumatoid arthritis – evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology 176:473–477
Konig H, Sieper J, Wolf KJ (1990) Dynamic MRI for the differentiation of inflammatory joint lesions. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 153:1–5
Ross JS, Delamarter R, Hueftle MG et al (1989) Gadolinium-DTPA-enhanced MRI of the postoperative lumbar spine: time course and mechanism of enhancement. AJR Am J Roentgenol 152:825–834
Verstraete KL, Dierick A, De Deene Y et al (1994) First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MRI. Magn Reson Imaging 12:687–702
Bollow M, Braun J, Hamm B et al (1995) Early sacroiliitis in patients with spondyloarthropathy – evaluation with dynamic gadolinium-enhanced MR-imaging. Radiology 194:529–536
Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Dipaola R (1992) Factor-analysis of dynamic magnetic-resonance-imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 27:847–855
Charpentier E et al (1990) Factor analysis processing of dynamic MRI: new method to assess osteosarcoma preoperative chemotherapy response (abstract). Radiology 177(Suppl):221
Cova M, Kang YS, Tsukamoto H et al (1991) Bone-marrow perfusion evaluated with gadolinium-enhanced dynamic fast MR imaging in a dog-model. Radiology 179:535–539
Erlemann R, Reiser MF, Peters PE et al (1989) Musculoskeletal neoplasms – static and dynamic Gd-DTPA enhanced MR imaging. Radiology 171:767–773
Erlemann R, Sciuk J, Bosse A et al (1990) Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy – assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 175:791–796
Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA (1992) Pediatric musculoskeletal tumors – use of dynamic contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 184:243–248
Hanna SL, Fletcher BD, Fairclough DL, Le A (1990) Use of dynamic Gd-DTPA enhanced MRI in musculoskeletal malignancies (abstract). Proceedings of Society of Magnetic Resonance Imaging, p 9
Lang P, Stevens M, Vahlensieck M (1991) Rheumatoid arthritis of the hand and wrist: evaluation of soft-tissue inflammation and quantification of inflammatory activity using unenhanced and dynamic Gd-DTPA enhanced MRI (abstract). Proceedings of Society of Magnetic Resonance in Medicine p 66
Mirowitz SA, Totty WG, Lee JKT (1990) Evaluation of musculoskeletal masses with dynamic Gd-DTPA enhanced rapid-acquisition spin-echo imaging (abstract). Radiology 177(Suppl):221
Mirowitz SA, Totty WG, Lee JKT (1992) Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI. J Comput Assist Tomogr 16:120–125
Reiser MF, Bongartz GP, Erlemann R et al (1989) Gadolinium-DTPA in rheumatoid-arthritis and related diseases – first results with dynamic magnetic-resonance imaging. Skeletal Radiol 18:591–597
Sugimoto H, Miyaji N, Ohsawa T (1994) Carpal-tunnel syndrome – evaluation of median nerve circulation with dynamic contrast-enhanced MR-imaging. Radiology 190:459–466
Tsukamoto H, Kang YS, Jones LC et al (1992) Evaluation of marrow perfusion in the femoral-head by dynamic magnetic-resonance-imaging – effect of venous occlusion in a dog-model. Invest Radiol 27:275–281
Vanel D et al (1993) Dynamic contrast-enhanced subtraction MRI in follow-up of aggressive soft-tissue tumors: a prospective study of 74 patients (abstract). Radiology 189(Suppl):205
Vanel D, Shapeero LG, Debaere T et al (1994) MR-imaging in the follow-up of malignant and aggressive soft-tissue tumors – results of 511 examinations. Radiology 190:263–268
Verstraete K (1994) Dynamic contrast-enhanced MRI of tumor and tumor-like lesions of the musculoskeletal system, pp 63–185. Thesis, University of Gent, Gent, Belgium
Verstraete KL, Dierick A, De Deene Y et al (1993) First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MRI. Proc. Soc. Magn. Reson. Med. 2, New York 869
Verstraete KL, Vanzieleghem B, De Deene Y et al (1995) Static, dynamic and first-pass MRI of musculoskeletal lesions using gadodiamide injection. Acta Radiol 36:27–36
Chien D, Edelman RR (1991) Ultrafast imaging using gradient echos. Magn Reson Q 7:31–56
Haase A, Matthaei D, Bartkowski R, Duhmke E, Leibfritz D (1989) Inversion recovery snapshot FLASH MR imaging. J Comput Assist Tomogr 13:1036–1040
Haase A (1990) Snapshot FLASH MRI – applications to T1, T2, and chemical-shift imaging. Magn Reson Med 13:77–89
Van der Woude H et al (1995) Double slice dynamic contrast-enhanced subtraction MR images in 60 patients with musculoskeletal tumors or tumor-like lesions (abstract). Eur Radiol (Suppl 5):181
Van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AH, Nooy MA, Hogendoorn PC (1995) Osteosarcoma and Ewing’s sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol 165:593–8
Verstraete KL, Lang P (2000) Bone and soft tissue tumors: the role of contrast agents for MRI. Eur J Radiol 34:229–246
van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC et al (2004) Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MRI in prediction of malignancy. Radiology 233:493–502
Shapeero LG, Henry-Amar M, Vanel D (1992) Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MRI and skeletal scintigraphy. Invest Radiol 27:989–991
Kashanian FK, Goldstein HA, Blumetti RF, Holyoak WL, Hugo FP, Dolker M (1990) Rapid bolus injection of gadopentetate dimeglumine: absence of side effects in normal volunteers. AJNR Am J Neuroradiol 11:853–856
Chambers TP, Baron RL, Lush RM, Dodd GD, Miller WJ, Confer SR (1993) Hepatic CT enhancement – a method to demonstrate reproducibility. Radiology 188:627–631
Chambers TP, Baron RL, Lush RM (1994) Hepatic CT enhancement. 1. Alterations in the volume of contrast material within the same patients. Radiology 193:513–517
Chambers TP, Baron RL, Lush RM (1994) Hepatic CT enhancement. 2. Alterations in contrast material volume and rate of injection within the same patients. Radiology 193:518–522
Vanderwoude HJ, Bloem JL, Schipper J et al (1994) Changes in tumor perfusion induced by chemotherapy in bone sarcomas – color Doppler flow imaging compared with contrast-enhanced MR-imaging and 3-phase bone-scintigraphy. Radiology 191:421–431
Vaupel P, Kallinowski F, Okunieff P (1989) Blood-flow, oxygen and nutrient supply, and metabolic microenvironment of human-tumors – a review. Cancer Res 49:6449–6465
Reddick WE, Langston JW, Meyer WH et al (1994) Discrete signal-processing of dynamic contrast-enhanced MR-imaging – statistical validation and preliminary clinical-application. J Magn Reson Imaging 4:397–404
Lang P, Honda G, Roberts T et al (1995) Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic post-contrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 197:831–839
Erlemann R (1993) Dynamic gadolinium-enhanced MR imaging to monitor tumor response to chemotherapy. Radiology 186:904
Lawrence JA, Babyn PS, Chan HSL, Thorner PS, Pron GE, Krajbich IJ (1993) Extremity osteosarcoma in childhood – prognostic value of radiologic imaging. Radiology 189:43–47
Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G (1992) Survival, prognosis, and therapeutic response in osteogenic-sarcoma – the Memorial Hospital Experience. Cancer 69:698–708
Hudson M, Jaffe MR, Jaffe N et al (1990) Pediatric osteosarcoma – therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 8:1988–1997
Meyers PA, Heller G, Healey J et al (1992) Chemotherapy for nonmetastatic osteogenic-sarcoma – the Memorial Sloan-Kettering experience. J Clin Oncol 10:5–15
Oberlin O, Patte C, Demeocq F et al (1985) The response to initial chemotherapy as a prognostic factor in localized Ewing sarcoma. Eur J Cancer Clin Oncol 21:463–467
Rosen G, Caparros B, Huvos AG et al (1982) Preoperative chemotherapy for osteogenic-sarcoma – selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230
Winkler K, Beron G, Delling G et al (1988) Neoadjuvant chemotherapy of osteo-sarcoma – results of a randomized cooperative trial (Coss-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337
Raymond AK, Chawla SP, Carrasco CH et al (1987) Osteosarcoma chemotherapy effect – a prognostic factor. Semin Diagn Pathol 4:212–236
Erlemann R, Sciuk J, Wuisman P et al (1992) Dynamic MR tomography in diagnosis of inflammatory and tumorous space-occupying growths of the musculoskeletal system. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 156:353–359
Fletcher B, Hanna S (1989) Musculoskeletal neoplasms: dynamic Gd-DTPA-enhanced MRI (letter). Radiology 177:287–288
Carrasco CH, Charnsangavej C, Raymond AK et al (1989) Osteosarcoma – angiographic assessment of response to preoperative chemotherapy. Radiology 170:839–842
Chuang VP, Benjamin R, Jaffe N et al (1982) Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roentgenol 139:1065–1069
Knop J, Delling G, Heise U, Winkler K (1990) Scintigraphic evaluation of tumor-regression during preoperative chemotherapy of osteosarcoma – correlation of Tc-99m-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol 19:165–172
Kumpan W, Lechner G, Wittich GR et al (1986) The angiographic response of osteosarcoma following pre-operative chemotherapy. Skeletal Radiol 15:96–102
Biondetti PR, Ehman RL (1992) Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MRI. Radiology 183:845–848
Bloem JL, Reiser MF, Vanel D (1990) Magnetic resonance contrast agents in the evaluation of the musculoskeletal system. Magn Reson Q 6:136–163
Maas R (1992) Radiological-diagnosis of recurrent soft-tissue sarcoma. Radiologe 32:597–605
Reuther G, Mutschler W (1990) Detection of local recurrent disease in musculoskeletal tumors – magnetic-resonance-imaging versus computed-tomography. Skeletal Radiol 19:85–90
Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielmann M, Genin J (1987) Musculoskeletal tumors – follow-up with MR imaging after treatment with surgery and radiation-therapy. Radiology 164:243–245
Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16:407–422
Essig M, Shiroishi M, Nguyen T et al (2013) Perfusion MRI: the five most frequently asked technical questions. AJR Am J Roentgenol 200(1):24–34
Paldino MJ, Barboriak DP (2009) Fundamentals of quantitative dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am 17:277–289
Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232
Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172–187
Leach MO, Morgan B, Tofts PS et al (2012) Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 22:1465–1478
Costa FM, Ferreira EC, Vianna EM (2011) Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors. Magn Reson Imaging Clin N Am 19(1):159–180
Baur A, Reiser MF (2000) Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 29(10):555–562
Lang P, Wendland MF, Saeed M et al (1998) Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion weighted MR imaging. Radiology 206(1):227–235
Van Rijswijk CS, Kunz P, Hogendoorn PC et al (2002) Diffusion weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging 15(3):302–307
Nagata S, Nishimura H, Uchida M et al (2008) Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med 26:287–295
Maeda M, Matsumine A, Kato H et al (2007) Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient. J Magn Reson Imaging 25:119–204
Bley TA, Wieben O, Uhl M, Diffusion-weighted MR (2009) imaging in musculoskeletal radiology: applications in trauma, tumors, and inflammation. Magn Reson Imaging Clin N Am 17(2):263–275
Fayad LM, Barker PB, Jacobs MA et al (2007) Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol 188(6):1513–1520
Fayad LM, Bluemke DA, McCarthy EF, Weber KL et al (2006) Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 23(1):23–28
Doganay S, Altinok T, Alkan A et al (2011) The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Eur J Radiol 20(2):219–225
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Verstraete, K.L., Dutoit, J.C., Drapé, J.L., Bloem, J.L. (2017). Magnetic Resonance Imaging: Advanced Imaging Techniques. In: Vanhoenacker, F., Parizel, P., Gielen, J. (eds) Imaging of Soft Tissue Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-46679-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-46679-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46677-4
Online ISBN: 978-3-319-46679-8
eBook Packages: MedicineMedicine (R0)